Amanta Healthcare Limited IPO
MainboardListed On: Sep 9, 2025 at ₹ 135.0(NSE)
₹ 14994 /119 Shares
Check AllotmentAmanta Healthcare IPO Live Subscription Details
Bids below ₹10L: 176.02x
NII Total: 209.42
01 Sep, 2025
Open Date03 Sep, 2025
Close Date04 Sep, 2025
Allotment Date09 Sep, 2025
Listing DateIssue Price
₹120-126 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
MUFG Intime India Pvt LtdList Price
135.0(NSE)Listing Date
2025-09-09Market Lot
Retail : 119 Shares (₹14,994/-)S-HNI : 1,666 Shares (₹2,09,916/-)
B-HNI : 7,973 Shares (₹10,04,598/-)
Lead Manager
Beeline Capital Advisors Pvt LtdIssue Size
1,00,00,000 shares(aggregating up to ₹126.0 Cr)Retail Portion
35% (Number of Retail Applications: 29,412 Approx),(Number of S-HNI Applications : 300 Approx),
(Number of B-HNI Applications : 600 Approx)
Subscription
82.60 timesAmanta Healthcare IPO Details
Amanta Healthcare IPO is a book-built issue of ₹126 crores, The total issue size is ₹126 crores. The IPO of Amanta Healthcare is priced at ₹120-126 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Sep 1, 2025 and ends on Sep 3, 2025. The allotment for Amanta Healthcare IPO will be finalized on Sep 4, 2025. Amanta Healthcare IPO will be listed on BSE, NSE, with a tentative listing date fixed as Sep 9, 2025. The company shall list its equity shares on the BSE, NSE. MUFG Intime India Pvt Ltd is the registrar of the issue.
Retail investors can bid for a minimum of 119 shares, extendable to 14,994. S-HNIs will be able to bid for 1,666 shares at ₹2,09,916, while B-HNIs can also apply for a bid of 7,973 shares at ₹10,04,598. The book-running lead manager for the IPO is/are Beeline Capital Advisors Pvt Ltd.
The total issue ₹126 crore, comprising a fresh issue of 1,00,00,000 shares ₹126 crore and
The Amanta Healthcare IPO sets its price band at 120-126 for each share. A single application for Amanta Healthcare Limited IPO must contain at least 119 shares. Sentiment investors need to invest a minimum of 119 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,994 In order to participate in the sNII, investors must purchase at least 14 lots of 1,666 shares for ₹2,09,916, while the bNII requires 67 lots of 7,973 shares for an investment of ₹10,04,598.
Amanta Healthcare IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 20,00,000 | 15,00,000 10,00,000 5,00,000 | 35,00,000 | 70,00,000 |
| Day 1 - 01-09-25 05:00 PM | 0.04 x | 5.82 4.24 x 8.98 x | 6.71 x | 4.61 x |
| Day 2 - 02-09-25 05:00 PM | 0.53 x | 36.40 30.03 x 49.13 x | 23.33 x | 19.62 x |
| Day 3 - 03-09-25 05:00 PM | 35.86 x | 209.40 226.13 x 175.96 x | 54.96 x | 82.60 x |
Amanta Healthcare Valuations
EPS Pre IPO
₹3.64/-EPS Post IPO
₹2.70/-P/E Pre IPO
34.59P/E Post IPO
46.59ROE
12.42%ROCE
13.72%Debt/Equity
2.02RoNW
10.89%PAT Margin
3.86%Price to Book Value
3.77Amanta Healthcare Company Financials All values are in ₹ Cr.
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Revenue | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| Net Worth | 96.39 | 66.29 | 62.88 |
| Reserves & Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
About The Company
Established in December 1994, Amanta Healthcare Limited is a pharma firm that focuses on the manufacturing, development, and marketing of a wide range of sterile liquid items, namely parenteral items, packaged in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also engages in the manufacturing of medical devices.The company produces formulations for fluid therapy, such as IV fluids, diluents, ophthalmic solutions, and respiratory care products. The company also sells irrigation solutions, first-aid items, and eye lubricants in the medical device market.
The company sells products through three business divisions:
National sales
International sales
Product partnering with several foreign and Indian pharma companies.
The company produces more than 45 generic items, selling them under their brand names in India through 320 stockists and distributors.The firm markets products in Africa, Latin America, the UK, and overseas. It has registered its products in 19 countries and meets numerous regulations. During Fiscal 2025, the firm shipped branded goods to 21 countries.
As of March 31, 2025, the firm employs a workforce of 1,718 at its formulation and development and quality laboratory.
Amanta Healthcare - Strength and Weakness
Established in 1994 with diversified pharmaceutical product portfolio
Advanced sterile liquid manufacturing across wide volume range
Certified facility with ISO, WHO-GMP, and advanced technologies
Experienced leadership with skilled, qualified employee base
High customer concentration poses revenue stability and dependency risks
Delay in SteriPort/SVP expansion may impact growth plans
Sterile liquid products carry serious product liability exposure
Unsecured borrowings and personal guarantees increase financial vulnerability
Amanta Healthcare - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Net Worth | |
|---|---|---|---|---|
| Amanta Healthcare | 3.77 | 46.5 | 10.9% | 276 |
| Denis Chem | 1.53 | 15.5 | 9.77% | 175 |
Amanta Healthcare - Promoter(s)
Pre Issue Share Holding: 85.60%
Post Issue Share Holding: 63.56%
- Bhavesh Patel
- Vishal Patel
- Jayshreeben Patel
- Jitendra Kumar Patel
- Milcent Appliances Private Limited
Amanta Healthcare IPO - Issue Objectives
- Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
- General corporate purposes
Amanta Healthcare IPO - Anchor Investors
Out Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and FinavenueFund came through its Small Cap Fund.Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and Finavenue Capital Trust were some other institutional investors that came on board for the anchor book.
Other Details
Amanta Healthcare
8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058MUFG Intime India Private Limited (Link Intime)
Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Amanta Healthcare IPO - FAQs
Ans. Amanta Healthcare Limited IPO is a Mainboard IPO. The issue is priced at ₹120-126 per equity share. The minimum order quantity is 119 Shares. The IPO opens on Sep 1, 2025, and closes on Sep 3, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Amanta Healthcare Limited IPO opens on Sep 1, 2025 and closes on Sep 3, 2025.
Ans. The size of Amanta Healthcare Limited IPO is 1,00,00,000 shares(aggregating up to ₹126.0 Cr).
Ans. The IPO price band is set between ₹120-126 per equity share.
Ans. To apply for Amanta Healthcare Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Amanta Healthcare Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Amanta Healthcare Limited IPO is Sep 4, 2025.
Ans. The Amanta Healthcare Limited IPO will be listed on Sep 9, 2025.
Ans. Follow the steps to check the allotment status for Amanta Healthcare Limited IPO here.
